Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA

X-Ray Crystallography Offers First-Time 3D View of Vital Brain Receptor

By BiotechDaily International staff writers
Posted on 07 Jul 2014
Image: X-ray crystal structure of the NMDA receptor showing its mushroom-like shape, with receptor subunits in different colors (Photo courtesy of Oregon Health & Science University).
Image: X-ray crystal structure of the NMDA receptor showing its mushroom-like shape, with receptor subunits in different colors (Photo courtesy of Oregon Health & Science University).
Researchers have produced a new and extraordinary three-dimensional (3D) view of one of the most important receptors in the brain—a receptor that allows humans to learn and remember, and whose malfunctioning is involved in a wide variety of neurologic disorders, including Alzheimer’s, Parkinson’s, depression, and schizophrenia.

The never-before-seen view provided was published online June 22, 2104, in the journal Nature, and offers new clues into how the receptor, called the N-methyl-D-aspartate (NMDA) receptor, is structured. Moreover, the new detailed view offers vital clues to developing drugs to fight the neurologic diseases and conditions. “This is the most exciting moment of my career,” said Dr. Eric Gouaux, a senior scientist at the Oregon Health & Science University’s Vollum Institute (OHSU; Portland, USA). “The NMDA receptor is one of the most essential, and still sometimes mysterious, receptors in our brain. Now, with this work, we can see it in fascinating detail.”

The NMDA receptor is one of the most significant brain receptors because it helps in neuron communication that is the basis of memory, learning, and thought. Dysfunction of the NMDA receptor occurs when it is more or less active and is tied to a wide range of neurologic disorders and diseases.

Scientists worldwide study the NMDA receptor; some of the most notable discoveries about the receptor during the past 30 years have been made by OHSU Vollum scientists.

The NMDA receptor structure includes receptor subunits, all of which have distinctive characteristics and act in distinct ways in the brain, sometimes causing neurologic difficulties. Before this research, scientists had only an inadequate view of how those subtypes were arranged in the NMDA receptor complex and how they interacted to carry out specific functions within the brain and central nervous system.

The team of scientists created a 3D model of the NMDA receptor through a process called X-ray crystallography. This process throws X-ray beams at crystals of the receptor; a computer calibrates the composition of the structure based on how those X-ray beams spring off the crystals. The resulting 3D model of the receptor, which looks similar to an arrangement of flowers, reveals where the receptor subunits are positioned, and offers unprecedented insights into their actions. “This new detailed view will be invaluable as we try to develop drugs that might work on specific subunits and therefore help fight or cure some of these neurological diseases and conditions,” Dr. Gouaux said. “Seeing the structure in more detail can unlock some of its secrets—and may help a lot of people.”

Related Links:

Oregon Health & Science University’s Vollum Institute



Channels

Genomics/Proteomics

view channel
Image: In mice, mitochondria (green) in healthy (left) and Mfn1-deficient heart muscle cells (center) are organized in a linear arrangement, but the organelles are enlarged and disorganized in Mfn2-deficient cells (right) (Photo courtesy of the Rockefeller Press).

Cell Biologists Find That Certain Mitochondrial Diseases Stem from Coenzyme Q10 Depletion

A team of German cell biologists has linked the development of certain mitochondrial-linked diseases to depletion of the organelles' pool of coenzyme Q10 brought about by mutation in the MFN2 gene, which... Read more

Drug Discovery

view channel
Image: Molecular model of the protein Saposin C (Photo courtesy of Wikimedia Commons).

Nanovesicles Kill Human Lung Cancer Cells in Culture and in a Mouse Xenograft Model

Nanovesicles assembled from the protein Saposin C (SapC) and the phospholipid dioleoylphosphatidylserine (DOPS) were shown to be potent inhibitors of lung cancer cells in culture and in a mouse xenograft model.... Read more

Biochemistry

view channel

Possible New Target Found for Treating Brain Inflammation

Scientists have identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited eurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that suppress this enzyme.... Read more

Business

view channel

Roche Acquires Signature Diagnostics to Advance Translational Research

Roche (Basel, Switzerland) will advance translational research for next generation sequencing (NGS) diagnostics by leveraging the unique expertise of Signature Diagnostics AG (Potsdam, Germany) in biobanks and development of novel NGS diagnostic assays. Signature Diagnostics is a privately held translational oncology... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.